- Home
- ATER vs BGLC Comparison
ATER vs BGLC Comparison
Compare ATER & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- BGLC
- Stock Information
- Founded
- ATER 2014
- BGLC 2017
- Country
- ATER United States
- BGLC Malaysia
- Employees
- ATER N/A
- BGLC N/A
- Industry
- ATER Home Furnishings
- BGLC Medical Specialities
- Sector
- ATER Consumer Discretionary
- BGLC Health Care
- Exchange
- ATER Nasdaq
- BGLC Nasdaq
- Market Cap
- ATER 10.3M
- BGLC 10.4M
- IPO Year
- ATER N/A
- BGLC N/A
- Fundamental
- Price
- ATER $0.90
- BGLC $5.25
- Analyst Decision
- ATER
- BGLC
- Analyst Count
- ATER 0
- BGLC 0
- Target Price
- ATER N/A
- BGLC N/A
- AVG Volume (30 Days)
- ATER 78.4K
- BGLC 97.4K
- Earning Date
- ATER 11-13-2025
- BGLC 11-14-2025
- Dividend Yield
- ATER N/A
- BGLC N/A
- EPS Growth
- ATER N/A
- BGLC N/A
- EPS
- ATER N/A
- BGLC N/A
- Revenue
- ATER $85,668,000.00
- BGLC $9,551,559.00
- Revenue This Year
- ATER N/A
- BGLC N/A
- Revenue Next Year
- ATER $7.48
- BGLC N/A
- P/E Ratio
- ATER N/A
- BGLC N/A
- Revenue Growth
- ATER N/A
- BGLC 4.01
- 52 Week Low
- ATER $0.90
- BGLC $2.01
- 52 Week High
- ATER $3.50
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- ATER 31.31
- BGLC 49.10
- Support Level
- ATER $0.95
- BGLC $5.00
- Resistance Level
- ATER $0.99
- BGLC $5.65
- Average True Range (ATR)
- ATER 0.05
- BGLC 0.34
- MACD
- ATER -0.01
- BGLC 0.02
- Stochastic Oscillator
- ATER 0.00
- BGLC 47.32
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.